Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
hACC2-IN-1
Cat. No.:
OB0425LY-157
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
hACC2-IN-1 is an inhibitor of human fatty acid synthase (ACC2) that promotes fatty acid oxidation and inhibits fatty acid synthesis.
Synonyms:
192323-14-1; tert-Butyl (((1R,4R)-4-((naphthalene-2-sulfonamido)methyl)cyclohexyl)methyl)carbamate; tert-Butyl [(trans-4-{[(2-naphthylsulfonyl)-amino]methyl}cyclohexyl)methyl]carbamate
CAS No.:
192323-14-1
Compound CID:
54104450
Formula:
C23H32N2O4S
Formula Weight:
432.58
Specification
Target:
Acetyl-CoA carboxylase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
hACC2-IN-1 is mainly used to study drug development for metabolic diseases, especially in the areas of obesity, diabetes and cardiovascular diseases.
